Related Experiment Video
Updated: Jun 8, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Autoantibodies in type 1 diabetes
Panagiotis Heras1, Marios Mantzioros, Dimitrios Mendrinos
1Hellenic Medical Society for the Study of Psychosomatic Disorders, Athens, Greece. panheras@yahoo.com
Diabetes Research and Clinical Practice
|September 14, 2010
Summary
Researchers investigated autoantibodies in people with Type 1 diabetes, an autoimmune condition affecting pancreatic beta-islet cells. This study sought to identify specific autoantibodies linked to this complex autoimmune disease.
Area of Science:
- Immunology
- Endocrinology
- Autoimmune Diseases
Background:
- Type 1 diabetes is an autoimmune disorder characterized by the destruction of pancreatic beta-islet cells.
- Type 1 diabetes is frequently associated with other autoimmune conditions, suggesting a shared underlying pathophysiology.
- Identifying specific autoantibodies can aid in understanding disease mechanisms and potential diagnostic markers.
Purpose of the Study:
- To investigate the presence and profile of autoantibodies in the serum of individuals diagnosed with Type 1 diabetes.
- To explore potential associations between specific autoantibodies and Type 1 diabetes.
- To contribute to the understanding of the autoimmune processes involved in Type 1 diabetes.
Main Methods:
- Serum samples were collected from individuals with Type 1 diabetes.
- Various autoantibody detection assays were employed (specific assays not detailed in abstract).
- Statistical analyses were performed to identify significant autoantibody findings.
Main Results:
- The study aimed to identify autoantibodies in the serum of people with Type 1 diabetes.
- Results regarding the specific autoantibodies detected and their prevalence are expected.
- The findings will shed light on the autoimmune targets in Type 1 diabetes.
Conclusions:
- The presence of specific autoantibodies in Type 1 diabetes patients is anticipated.
- Understanding these autoantibodies may offer insights into disease pathogenesis and progression.
- Further research is warranted to explore the clinical utility of these autoantibody findings.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...